In contrast, heterozygous deletion of PMP22 (approximately 0.5-fold reduction in expression) leads to another demyelinating neuropathy, Hereditary Neuropathy with Liability to Pressure Palsies (HNPP) (4, 10, 17, 18). Here, PMP22 is linked to hereditary neuropathy with liability to pressure palsies.